TrialAbout TrialRedline
What does TrialRedline do?
TrialRedline tracks changes to clinical trial records on ClinicalTrials.gov, the public trial registry. It shows previous and updated completion dates, participant counts, study status and primary outcome measures, with links to the original records.
Who is it for?
Biotech analysts and investment researchers use it to check changes while researching companies. Biotech and competitive intelligence teams use it to follow competitors. Journalists use it to inspect and cite the trial record.
How do I use it?
Search for a company, ticker or trial ID, then open a trial to compare the changes we have recorded. Create a free account to follow up to three listed companies and receive a weekly email digest. The FDA calendar also lists the regulatory events we have verified against sources.
What does it cover?
Initial coverage focuses on company-sponsored Phase 2/3 drug trials linked to US-listed companies. Historical records are partial; trial pages explain the gaps. TrialRedline does not provide patient matching, market prices, trading signals or investment recommendations.